Skip to main content
TipRanks
Go Ultimate75% OFF

BioAtla (BCAB) Q3 2024 Earnings Report

785 Followers

BCAB Q3 2024 EPS Results

Actual EPS
-$11.00
Consensus EPS
-$20.67
Beat/Miss
Beat by +$9.67
One Year Ago EPS
-$35.00

BCAB Q3 2024 Revenue Results

Actual Revenue
$11.00M
Expected Revenue
$0
Beat/Miss
Beat by +$11.00M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2024
Date
11/07/2024
Time
After Close
Conference Call
Thursday, November 7, 2024

Q3 2024 Earnings Call Audio

BCAB Q3 2024 Earnings Call
0:00 / 0:00

Q3 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

BCAB Earnings History

BCAB earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20262026 (Q3)―--0.27―
Aug 06, 20262026 (Q2)―0.27-16101.70% (+16.27)
May 13, 20262026 (Q1)―--0.26―
Mar 31, 20262025 (Q4)-12.00-8.00-1338.46% (+5.00)
Nov 13, 20252025 (Q3)-14.83-13.50-11-22.73% (-2.50)
Aug 07, 20252025 (Q2)-14.00-16.00-2227.27% (+6.00)
May 06, 20252025 (Q1)-14.67-13.00-2445.83% (+11.00)
Mar 27, 20252024 (Q4)-19.25-15.00-2846.43% (+13.00)
Nov 07, 20242024 (Q3)-20.67-11.00-3568.57% (+24.00)
Aug 08, 20242024 (Q2)-22.40-22.00-37.541.33% (+15.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed